Jacques H. Grosset

Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

N. Lounis, C. Truffot-Pernot, B. Ji, 1997, Antimicrobial agents and chemotherapy.

New drugs for the treatment of tuberculosis: hope and reality [State of the Art Series. New tools. Number 2 in the series].

W. Bishai, J. Grosset, T. G. Singer, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility.

V. Jarlier, W. Sougakoff, J. Grosset, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice

B. Ji, J. Grosset, E. Perani, 1996, Antimicrobial agents and chemotherapy.

Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

J. Grosset, E. Perani, B. Ji, 1990, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Activity of ofloxacin against Mycobacterium leprae in the mouse.

J. Grosset, E. Perani, C. C. Guelpa-Lauras, 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.